CED, the Southeast's largest entrepreneurial support organization, today
announced the agenda and speakers for the CED
Life Science Conference 2013, February 27-28, 2013, in Raleigh,
North Carolina. The North Carolina Biotechnology Center and North
Carolina Biosciences (NCBIO) are presenting partners.
The keynote speakers at the CED Life Science Conference 2013 are N.
Anthony (Tony) Coles, M.D., chairman and CEO, Onyx Pharmaceuticals,
Inc.; Dr. Samuel Nussbaum, M.D., executive vice president, Clinical
Health Policy and chief medical officer, WellPoint, Inc.; and Jack W.
Szostak, Ph.D., recipient of the 2009 Nobel Prize in physiology or
medicine, investigator, Howard Hughes Medical Institute, and professor
of genetics, Harvard Medical School.
The conference co-chairs are David P. King, CEO, LabCorp; Ed Mathers,
partner, NEA; and Bradley Wilson, president and CEO, Blue Cross andBlue
Shield of North Carolina. The CED Life Science Conference attracts more
than 1,000 life science entrepreneurs, investors and industry
Early registration discounts are available through January 25, 2013. To
register or view the full conference agenda, visit the CED Life Science
Conference 2013 site at http://www.cednc.org/lifescience.
"This conference is a must-attend event for those in the life science
industry," said David King, CEO of LabCorp, who will lead a panel on
leadership. "We have secured an impressive lineup of opinion leaders,
who will speak to the critical challenges and opportunities that lie
"The conference represents the largest regional gathering of the life
science community," said CED president Joan Siefert Rose. "This year's
program includes a showcase of up-and-coming companies, updates on
policy affecting the industry, and excellent opportunities for
high-level networking," Rose said. The conference is now in its 22nd
CED's mission is to identify, enable and promote emerging growth
companies and to accelerate the entrepreneurial culture of the Research
Triangle and North Carolina.
About NC Biotechnology Center
The Biotechnology Center is a private, non-profit corporation supported
by the N.C. General Assembly. Its mission is to provide long-term
economic and societal benefits to North Carolina by supporting
biotechnology research, business, education and strategic policy
NCBIO is dedicated to promoting the future growth and development of
North Carolina's bioscience industry. NCBIO advocates for state and
federal public policies that encourage the growth of life science
companies, support the development of a strong life science workforce,
and promote research and technology transfer at universities and other
[ Back To NFVZone's Homepage ]